|
|
Article: Over-Allotment Option Exercised in Sequana Therapeutics, Inc. Public Offering.
- Article from:
- Business Wire
- Article date:
- April 4, 1996
CopyrightCOPYRIGHT 1996 Business Wire. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
LA JOLLA, Calif.--(BUSINESS WIRE)--April 4, 1996--Sequana Therapeutics, Inc. (Nasdaq: SQNA) Thursday announced that the 255,000-share over-allotment was exercised in connection with the Company's recently completed public offering.
Hambrecht & Quist LLC., lead underwriter for the offering, has notified Sequana that it has exercised its right to purchase from certain selling shareholders an aggregate of 255,000 shares of Common Stock at a per share price of $19.00. The Company will not receive any proceeds from the sale of shares by the selling shareholders. Sequana completed a public offering of 1,700,000 shares of Common Stock on March 7, 1996.
Sequana ...
Related newspaper, magazine, and journal articles:
|
|
Article: Sequana Therapeutics reports 1996 third-quarter ...
Business Wire;
October 24, 1996 ;
700+ words
... ... BUSINESS WIRE)--Oct. 24, 1996--Sequana Therapeutics Inc. (NASDAQ:SQNA) Thursday ... equivalents and investment securities. Sequana Therapeutics is a leading genomics company that ... director, investor relations, Sequana Therapeutics, at 619/646-8313, or visit ...
|
|